Wuhan Hvsen Biotechnology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	398.32	310.2	326.14	293.61	424.04	1,068
Trading Asset Securities	211.93	160.33	200.97	304.26	361.68	30.22
Cash & Short-Term Investments	610.25	470.53	527.11	597.87	785.72	1,098
Cash Growth	7.13%	-10.73%	-11.83%	-23.91%	-28.47%	39.57%
Accounts Receivable	539.16	456.32	446.27	369.11	354.41	249.4
Other Receivables	17.35	24.74	19.8	7.42	1.7	10.07
Receivables	556.52	481.06	466.07	376.53	356.11	259.46
Inventory	275.56	267.89	248.16	228.67	199.01	231.55
Other Current Assets	56.6	87.45	71.24	62.91	10.64	9.42
Total Current Assets	1,499	1,307	1,313	1,266	1,351	1,599
Property, Plant & Equipment	1,537	1,551	1,543	1,566	1,498	1,007
Goodwill	0.52	0.52	-	-	-	-
Other Intangible Assets	109.54	110.57	114.44	104.17	106.87	110.06
Long-Term Deferred Tax Assets	25.56	23.45	27.17	21.65	12.91	10.46
Long-Term Deferred Charges	0.86	0.95	1.9	2.72	0.37	-
Other Long-Term Assets	74.12	14.9	15.25	14.78	19.4	15.46
Total Assets	3,248	3,009	3,015	2,975	2,989	2,742
Accounts Payable	442	391.2	507.3	472.47	489.7	311.33
Accrued Expenses	20.52	34.47	22.88	26.72	33.67	27.59
Short-Term Debt	185.88	173.85	316.78	240.32	220.08	100
Current Portion of Long-Term Debt	16.01	30.03	16.32	0.27	-	-
Current Portion of Leases	-	-	-	-	-	6.42
Current Income Taxes Payable	24.22	11.02	0.04	3.17	6.25	2.56
Current Unearned Revenue	23.57	19.51	13.47	10.27	15.62	13.87
Other Current Liabilities	65.66	80.26	46.52	27.86	39.6	41.5
Total Current Liabilities	777.87	740.33	923.32	781.08	804.93	503.27
Long-Term Debt	140.16	24.72	555.45	601.66	570.36	574.56
Long-Term Unearned Revenue	57.74	52.57	58.34	62.34	48.89	42.08
Long-Term Deferred Tax Liabilities	2.71	2.8	11.37	20.26	21.82	-
Other Long-Term Liabilities	1.75	1.75	1	0.85	1.69	2.9
Total Liabilities	980.24	822.17	1,549	1,466	1,448	1,123
Common Stock	201.78	202.33	165.77	165.89	166.05	166.25
Additional Paid-In Capital	1,439	1,451	880.63	874.01	877.08	881.6
Retained Earnings	619.43	541.76	330.21	394.92	427.11	429.31
Treasury Stock	-1.3	-18.09	-17.57	-52.42	-55.73	-9.52
Comprehensive Income & Other	-4.45	-3.78	98.54	126.89	126.92	151.21
Total Common Equity	2,255	2,174	1,458	1,509	1,541	1,619
Minority Interest	13.39	12.78	7.63	-	-	-
Shareholders' Equity	2,268	2,186	1,465	1,509	1,541	1,619
Total Liabilities & Equity	3,248	3,009	3,015	2,975	2,989	2,742
Total Debt	342.05	228.6	888.56	842.24	790.45	680.98
Net Cash (Debt)	268.2	241.93	-361.45	-244.38	-4.72	417.47
Net Cash Growth	-	-	-	-	-	-41.03%
Net Cash Per Share	1.33	1.23	-2.18	-1.47	-0.03	2.52
Filing Date Shares Outstanding	202.33	201.78	165.01	163.5	163.67	166.25
Total Common Shares Outstanding	202.33	201.58	165.01	163.5	163.67	166.25
Working Capital	721.05	566.6	389.27	484.9	546.55	1,096
Book Value Per Share	11.14	10.78	8.83	9.23	9.42	9.74
Tangible Book Value	2,145	2,063	1,343	1,405	1,435	1,509
Tangible Book Value Per Share	10.60	10.23	8.14	8.59	8.77	9.08
Buildings	-	673.15	670.73	647.31	521.54	385.01
Machinery	-	1,305	1,231	1,135	798.62	204.86
Construction In Progress	-	58.93	18.15	53.13	332.51	473.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.